Advertisement

PharmacoEconomics & Outcomes News

, Volume 825, Issue 1, pp 33–33 | Cite as

Durvalumab recommended through CDF for lung cancer

News item
  • 2 Downloads

Reference

  1. NICE. Promising lung cancer treatment approved for Cancer Drugs Fund. Internet Document : 28 Mar 2019. Available from: URL: https://www.nice.org.uk/news/article/promising-lung-cancer-treatment-approved-for-cancer-drugs-fund

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations